Uploaded August 2026 | Updated September 2026, 6 hours ago
Could GLP-1 medications play a role in treating bulimia or binge eating disorder? In this episode of Metabolic Mind, Dr. Bret Scher speaks with Paige Gordon and psychiatrist Dr. Michael Lutter about Paige’s personal experience using a GLP-1 medication for treatment-resistant bulimia, and why researchers are beginning to explore the neurobiology of binge eating.
Paige shares how years of therapy and medication never quieted the overwhelming binge urges that drove her bulimia. After hearing someone describe their experience on a podcast, she began exploring GLP-1 medication and saw a profound change in her urges and eating patterns. Dr. Lutter adds the scientific context, including genetic findings that may help explain why some people with binge eating or bulimia respond strongly to GLP-1 medications.
They cover:
- How Paige’s bulimia began and why standard treatments didn’t fully help
- What “food noise” felt like in her lived experience
- Why GLP-1 medications may affect appetite, reward pathways, and binge urges
- How genetics may help identify who responds to GLP-1s
- Why eating disorder treatment needs more precision-focused research
- The risks of using GLP-1 medications in people with restrictive eating disorders
- Why stigma keeps many people from discussing this treatment openly
This conversation explores an emerging area of eating disorder research with hope, caution, and a clear need for larger clinical trials.
👉 Want to stay up to date with the latest research on metabolic health and metabolic psychiatry? Sign up for our newsletter to stay informed: metabolicmind.org/about-us/newsletter
🔎 Have questions about how to apply metabolic therapies effectively? Submit them at metabolicmind.org/questions to be featured in a future Metabolic Mailbag episode.
#MetabolicMind #GLP1 #EatingDisorderTreatment
*Expert Featured:*
Paige Gordon
- paigegordonauthor.com
- instagram.com/paigegordonauthor
- linkedin.com/in/paigegordon
- tiktok.com/@paigegordonauthor
Dr. Michael Lutter
- precision-psychiatry.com
- linkedin.com/in/michaelluttermd
- youtube.com/@precisionpsychiatry
*Free CME Clinician Trainings:*
Are you a clinician who would like to learn more about the science behind these therapies and how to implement them in practice? Earn CME with our growing library of courses from some of the top experts in the field including Dr. Chris Palmer, Dr. Georgia Ede, Dr. Matthew Bernstein, Dr. Mariela Glandt, Dr. Deanna Kelly, Dr. Julie Milder, Dr. Zoltan Sarnyai, and Dr. Bret Scher with more coming soon.
Our courses have been made *FREE* by grants from Baszucki Group, so we can spread these powerful therapies as widely as possible. Earn CME/CNE credits:
metabolicmind.org/for-clinicians/trainings-courses/?utm_medium=organic-social&utm_source=youtube&utm_campaign=cme-yt
Follow our channel for more information and education from Bret Scher, MD, FACC, including interviews with leading experts in Metabolic Psychiatry.
Learn more about metabolic psychiatry and find helpful resources at metabolicmind.org
*About us:*
Metabolic Mind is a non-profit initiative of Baszucki Group working to transform the study and treatment of mental disorders by exploring the connection between metabolism and brain health. We leverage the science of metabolic psychiatry and personal stories to offer education, community, and hope to people struggling with mental health challenges and those who care for them.
Our channel is for informational purposes only. We are not providing individual or group medical or healthcare advice nor establishing a provider-patient relationship. Many of the interventions we discuss can have dramatic or potentially dangerous effects if done without proper supervision. Consult your healthcare provider before changing your lifestyle or medications.
*Timestamps:*
0:00 - Introduction: Could GLP-1s Be a New Treatment for Bulimia & Binge Eating Disorder?
4:15 - Paige Gordon's 26-Year Battle With Bulimia
8:35 - Why Eating Disorder Treatments So Often Fall Short
10:40 - The Moment Ozempic Silenced the "Food Noise"
13:45 - The Genetic Discovery That Changed Dr. Lutter's Thinking
15:50 - What Bulimia Remission Actually Felt Like After GLP-1 Therapy
20:30 - Which Patients Are Most Likely to Respond to GLP-1 Medications?
22:20 - Why We Need Better Research on GLP-1s for Eating Disorders
26:30 - The Connection Between Metabolic Health, Ketones, and Eating Disorders
29:27 - GLP-1s, Ketones & the Brain: Rethinking What Counts as a Psychotropic Treatment
31:53 - Semaglutide vs. Tirzepatide for Bulimia & Binge Eating: What Early Experiences Suggest
35:36 - Final Thoughts
Could GLP-1 medications play a role in treating bulimia or binge eating disorder? In this episode of Metabolic Mind, Dr. Bret Scher speaks with Paige Gordon and psychiatrist Dr. Michael Lutter about Paige’s personal experience using a GLP-1 medication for treatment-resistant bulimia, and why researchers are beginning to explore the neurobiology of binge eating.
Paige shares how years of therapy and medication never quieted the overwhelming binge urges that drove her bulimia. After hearing someone describe their experience on a podcast, she began exploring GLP-1 medication and saw a profound change in her urges and eating patterns. Dr. Lutter adds the scientific context, including genetic findings that may help explain why some people with binge eating or bulimia respond strongly to GLP-1 medications.
They cover:
- How Paige’s bulimia began and why standard treatments didn’t fully help
- What “food noise” felt like in her lived experience
- Why GLP-1 medications may affect appetite, reward pathways, and binge urges
- How genetics may help identify who responds to GLP-1s
- Why eating disorder treatment needs more precision-focused research
- The risks of using GLP-1 medications in people with restrictive eating disorders
- Why stigma keeps many people from discussing this treatment openly
This conversation explores an emerging area of eating disorder research with hope, caution, and a clear need for larger clinical trials.
👉 Want to stay up to date with the latest research on metabolic health and metabolic psychiatry? Sign up for our newsletter to stay informed: metabolicmind.org/about-us/newsletter
🔎 Have questions about how to apply metabolic therapies effectively? Submit them at metabolicmind.org/questions to be featured in a future Metabolic Mailbag episode.
#MetabolicMind #GLP1 #EatingDisorderTreatment
*Expert Featured:*
Paige Gordon
- paigegordonauthor.com
- instagram.com/paigegordonauthor
- linkedin.com/in/paigegordon
- tiktok.com/@paigegordonauthor
Dr. Michael Lutter
- precision-psychiatry.com
- linkedin.com/in/michaelluttermd
- youtube.com/@precisionpsychiatry
*Free CME Clinician Trainings:*
Are you a clinician who would like to learn more about the science behind these therapies and how to implement them in practice? Earn CME with our growing library of courses from some of the top experts in the field including Dr. Chris Palmer, Dr. Georgia Ede, Dr. Matthew Bernstein, Dr. Mariela Glandt, Dr. Deanna Kelly, Dr. Julie Milder, Dr. Zoltan Sarnyai, and Dr. Bret Scher with more coming soon.
Our courses have been made *FREE* by grants from Baszucki Group, so we can spread these powerful therapies as widely as possible. Earn CME/CNE credits:
metabolicmind.org/for-clinicians/trainings-courses/?utm_medium=organic-social&utm_source=youtube&utm_campaign=cme-yt
Follow our channel for more information and education from Bret Scher, MD, FACC, including interviews with leading experts in Metabolic Psychiatry.
Learn more about metabolic psychiatry and find helpful resources at metabolicmind.org
*About us:*
Metabolic Mind is a non-profit initiative of Baszucki Group working to transform the study and treatment of mental disorders by exploring the connection between metabolism and brain health. We leverage the science of metabolic psychiatry and personal stories to offer education, community, and hope to people struggling with mental health challenges and those who care for them.
Our channel is for informational purposes only. We are not providing individual or group medical or healthcare advice nor establishing a provider-patient relationship. Many of the interventions we discuss can have dramatic or potentially dangerous effects if done without proper supervision. Consult your healthcare provider before changing your lifestyle or medications.
*Timestamps:*
0:00 - Introduction: Could GLP-1s Be a New Treatment for Bulimia & Binge Eating Disorder?
4:15 - Paige Gordon's 26-Year Battle With Bulimia
8:35 - Why Eating Disorder Treatments So Often Fall Short
10:40 - The Moment Ozempic Silenced the "Food Noise"
13:45 - The Genetic Discovery That Changed Dr. Lutter's Thinking
15:50 - What Bulimia Remission Actually Felt Like After GLP-1 Therapy
20:30 - Which Patients Are Most Likely to Respond to GLP-1 Medications?
22:20 - Why We Need Better Research on GLP-1s for Eating Disorders
26:30 - The Connection Between Metabolic Health, Ketones, and Eating Disorders
29:27 - GLP-1s, Ketones & the Brain: Rethinking What Counts as a Psychotropic Treatment
31:53 - Semaglutide vs. Tirzepatide for Bulimia & Binge Eating: What Early Experiences Suggest
35:36 - Final Thoughts
